SEC Filing Summary

Mohideen Pharis, Chief Medical Officer of DBV Technologies S.A., reported a sale of 464 ordinary shares on July 29, 2026. The shares were sold at a price of $2.70 per share, for a total transaction value of $1,252.80. This transaction was made to cover withholding tax obligations upon the vesting of restricted stock units. Following this transaction, Pharis owns 144,531 ordinary shares. The price per share is reported in USD, reflecting a conversion from EUR at an exchange rate of 1 EUR to 1.1380 USD as of the transaction date.